<DOC>
	<DOCNO>NCT01472666</DOCNO>
	<brief_summary>Dairy food contains large amount long-chain saturate fat , traditionally link increase risk cardiovascular disease ( CVD ) . However , recent data indicate neutral role . Milk fat contains large amount medium-chain saturate fatty acid ( MC-SFA ) , may beneficial effect human health . In addition , milk protein particular whey protein show beneficial effect glucose disposal well anti-inflammatory property . Therefore dairy product potential role treatment metabolic abnormality metabolic syndrome ( MeS ) . However , human data intervention study lack . Aims project explore understand influence human health medium-chain saturate fatty acid milk fat bioactive milk protein per se well interaction potential positive synergy MeS . The investigator hypothesize whey protein medium-chain saturate fatty acid improve insulin sensitivity , postprandial lipid metabolism , blood pressure inflammatory stress human possess preventive effect risk develop CVD type 2 diabetes mellitus ( T2DM ) . A total 64 people MeS abdominal obesity include . The design randomize double-blinded , controlled parallel diet-intervention trial . Subjects assign one four experimental diet 12 week . The diet consist either diet low level MC-SFA + whey protein ( LF + whey ) , diet high MC-SFA + whey protein ( HF + whey ) , diet high MC-SFA + casein protein ( HF + casein ) diet low level MC-SFA + casein protein ( LF + casein ) . The subject advise integrate test food habitual diet , also continue unchanged . The subject ' energy intake match kept weight stable throughout study .</brief_summary>
	<brief_title>Dairy Lipids , Proteins , Metabolic Syndrome - `` DairyHealth ''</brief_title>
	<detailed_description>See .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Obesity , Abdominal</mesh_term>
	<mesh_term>Caseins</mesh_term>
	<criteria>Metabolic syndrome Central obesity ( Waist : female ≥ 80 cm ; male ≥ 94 cm ) two follow Fasting triglyceride &gt; 1.7 mmol/l HDLcholesterol ; male &lt; 1.03 mmol/l , female &lt; 1.29 mmol/l BP ≥ 130/85 Fasting plasma glucose ≥ 5,6 mmol/l ( diabetes ) Or abdominal obesity ( Waist : female ≥ 80 cm ; male ≥ 94 cm ) Significant cardiovascular , renal endocrine disease Psychiatric history Treatment steroid Alcohol drugaddiction Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Medium chain fatty acid</keyword>
	<keyword>Saturated fatty acid</keyword>
	<keyword>Whey protein</keyword>
	<keyword>Casein protein</keyword>
	<keyword>Metabolic syndrome</keyword>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Cardiovascular disease</keyword>
	<keyword>Dairy product</keyword>
	<keyword>Dietary intervention</keyword>
</DOC>